Jerrell Shelton Sells 2,631 Shares of Cryoport, Inc. (NASDAQ:CYRX) Stock

Cryoport, Inc. (NASDAQ:CYRX) CEO Jerrell Shelton sold 2,631 shares of the company’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $17.54, for a total value of $46,147.74. Following the completion of the transaction, the chief executive officer now directly owns 692,182 shares in the company, valued at $12,140,872.28. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Jerrell Shelton also recently made the following trade(s):

• On Monday, March 11th, Jerrell Shelton sold 3,723 shares of Cryoport stock. The stock was sold at an average price of $16.35, for a total value of $60,871.05.
• On Friday, March 15th, Jerrell Shelton sold 57,039 shares of Cryoport stock. The stock was sold at an average price of $15.30, for a total value of $872,696.70.

Cryoport Price Performance

Shares of NASDAQ:CYRX opened at $18.12 on Thursday. The business has a 50 day moving average price of $15.95 and a 200 day moving average price of $14.37. Cryoport, Inc. has a twelve month low of $9.00 and a twelve month high of $24.30. The company has a market cap of $887.52 million, a price-to-earnings ratio of -8.24 and a beta of 1.61. The company has a quick ratio of 11.16, a current ratio of 11.73 and a debt-to-equity ratio of 0.82.

Institutional Trading of Cryoport

Several hedge funds have recently added to or reduced their stakes in CYRX. Tower Research Capital LLC TRC boosted its stake in Cryoport by 228.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 2,060 shares of the company’s stock valued at $36,000 after purchasing an additional 1,433 shares during the period. Quarry LP bought a new stake in shares of Cryoport in the 2nd quarter worth approximately $40,000. State of Wyoming lifted its position in shares of Cryoport by 42.7% in the 4th quarter. State of Wyoming now owns 3,026 shares of the company’s stock worth $53,000 after acquiring an additional 905 shares during the period. Comerica Bank bought a new stake in shares of Cryoport in the 3rd quarter worth approximately $53,000. Finally, Natixis Investment Managers International lifted its position in shares of Cryoport by 61.5% in the 4th quarter. Natixis Investment Managers International now owns 4,536 shares of the company’s stock worth $70,000 after acquiring an additional 1,727 shares during the period. Institutional investors own 92.90% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on CYRX shares. Needham & Company LLC decreased their price target on Cryoport from $19.00 to $18.00 and set a “buy” rating for the company in a research note on Wednesday, March 13th. Stephens reiterated an “equal weight” rating and set a $17.00 price target on shares of Cryoport in a research note on Wednesday, March 13th. Finally, UBS Group upped their price target on Cryoport from $14.50 to $17.00 and gave the stock a “neutral” rating in a research note on Friday, March 15th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Cryoport has a consensus rating of “Hold” and a consensus price target of $18.29.

About Cryoport

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.